Anti-CRO Lindus Health Raises $55M in Series B Funding to Transform the Clinical Trial Landscape
NEW YORK, N.Y. — January 22, 2025 — Lindus Health, “the anti-CRO” running radically faster, more reliable clinical trials, announced today it has raised $55M in Series B funding. The…